Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Clinical and Experimental Hypertension is Scopus-indexed (Q1, CiteScore 6.5), WoS SCIE, DOAJ. Published by Taylor & Francis Group LLC Philadelphia.
Checked against the index lists dated .
ISSN 1064-1963Verify ISSN ↗1525-6006Verify ISSN ↗
Publisher: Taylor & Francis Group LLC Philadelphia
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Internal Medicine | 41 / 179 | 77th | Q1 |
| Physiology | 54 / 196 | 72nd | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1978–present, best quartile Q1, CiteScore 6.5.
Clinical and Experimental Hypertension is Q1 in Internal Medicine (rank 41 of 179) and Q2 in Physiology (rank 54 of 196), by CiteScore 2025.
Clinical and Experimental Hypertension is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.5, which places it in quartile Q1 at the 77th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.934, quartile Q1, with an H-index of 59.
Clinical and Experimental Hypertension is published by Taylor & Francis Group LLC Philadelphia. Its print ISSN is 1064-1963 and its online ISSN is 1525-6006.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Clinical and Experimental Hypertension has an h-index of 76 and a 2-year mean of 4.27 citations per paper (OpenAlex). Its Scopus CiteScore is 6.5, quartile Q1. On 2-year citations it ranks #29 of 172 Scopus journals in Internal Medicine.
Clinical and Experimental Hypertension published 52 papers in 2025; its busiest recent year was 2017 with 190. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2024–2026), authors are most often from China (77.8%), Türkiye (3.9%) and Japan (3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.4 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.